Genzyme's Ireland site expanded

Sanofi ($SNY) has expanded its Genzyme unit in Waterford, Ireland, 10 years after establishing it. CEO Christopher Viehbacher (photo) says was on hand with local officials at the inauguration of the $207 million campus expansion.

The site now boasts increased capacity for manufacturing operations, as well as additional development capability, lab facilities and administration offices. It currently employs 500, according to an announcement by economic development group IDA Ireland. The location has been home to oral dose manufacturing and packaging operations.

"Waterford is a strategic site within Genzyme," said Viehbacher, in the release. "Products from this location make a great difference in the lives of patients in more than 70 countries."

Sanofi offers "tremendous opportunities for growth for the Genzyme brand," added Genzyme senior VP for manufacturing ops Dominic Carolan.

- here's the release
- get more from RTE News

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.